1h Free Analyst Time
Global Biosurgery Market 2020-2024.Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the global biosurgery market and it is poised to grow by USD 4.81 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period. The report on the global biosurgery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing number of surgical procedures. In addition, constant technological advances is anticipated to boost the growth of the global biosurgery market as well.
Market Segmentation
The global biosurgery market is segmented as below:
Product:
- Soft-tissue Attachments
- Hemostatic Agents
- Bone Graft Substitutes
- Surgical Sealants
- Adhesives
- Adhesion Barriers
Geographic Segmentation:
- Asia
- Europe
- North America
- ROW
Key Trends for global biosurgery market growth
This study identifies constant technological advances as the prime reasons driving the global biosurgery market growth during the next few years.
Prominent vendors in global biosurgery market
The publisher a detailed analysis of around 25 vendors operating in the global biosurgery market , including some of the vendors such as B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., CSL Ltd., Getinge AB, Integra LifeSciences Holdings Corp., Johnson & Johnson, Medtronic Plc, Pfizer Inc. and Stryker Corp. .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Table of Contents
PART 01: EXECUTIVE SUMMARYPART 07: CUSTOMER LANDSCAPEPART 09: DECISION FRAMEWORK
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global biosurgery market : B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., CSL Ltd., Getinge AB, Integra LifeSciences Holdings Corp., Johnson & Johnson, Medtronic Plc, Pfizer Inc. and Stryker Corp. .Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the constant technological advances."
According to the report, one of the major drivers for this market is the increasing number of surgical procedures.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton
- Dickinson and Co.
- CSL Ltd.
- Getinge AB
- Integra LifeSciences Holdings Corp.
- Johnson & Johnson
- Medtronic Plc
- Pfizer Inc.
- Stryker Corp.
